Cabaletta Bio, Inc.
CABA · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: SCHEDULE 13G/A ·
Latest disclosures
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Tomasello Shawn: Form 4
Insider disclosure · Filed · Report period 09 Jun 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- CABA · 12674W109 - Common Stock
Company details and SEC sources
CIK 0001759138 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- CABA on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 2929 Arch Street, Suite 600, Philadelphia, PA, 19104
- Incorporated in
- DE
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields